Cargando…

Efficacy and safety of avatrombopag in aplastic anemia patients with liver disease

Detalles Bibliográficos
Autores principales:	Wang, Huaquan, He, Guangsheng, Jia, Jinsong, Liu, Mengyuan, Liu, Hui, Wang, Ting, Liu, Chunyan, Fu, Rong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Sciendo 2023
Materias:	Letter to Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10393059/ https://www.ncbi.nlm.nih.gov/pubmed/37533842 http://dx.doi.org/10.2478/jtim-2023-0006

Ejemplares similares

P763: EFFICACY AND SAFETY OF AVATROMBOPAG IN THE TREATMENT OF TRANSFUSION-DEPENDENT NON-SEVERE APLASTIC ANEMIA
por: Zhang, Ting, et al.
Publicado: (2023)

Abnormal Proteomics Profile of Plasma Reveals the Immunological Pathogenesis of Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2022)

Efficacy and safety of eltrombopag in Chinese patients with refractory or relapsed severe aplastic anemia
por: Chang, Hong, et al.
Publicado: (2023)

PKM2 Is Required to Activate Myeloid Dendritic Cells from Patients with Severe Aplastic Anemia
por: Liu, Chunyan, et al.
Publicado: (2018)

Effects of Shikonin on the Functions of Myeloid Dendritic Cells in a Mouse Model of Severe Aplastic Anemia
por: Zheng, Mengying, et al.
Publicado: (2020)

Detection and Significance of CD4+CD25+CD127dim Regulatory T Cells in Individuals with Severe Aplastic Anemia
por: Qi, Weiwei, et al.
Publicado: (2015)

The Clinical and Immune Characteristics of Patients with Hepatitis-Associated Aplastic Anemia in China
por: Wang, Huaquan, et al.
Publicado: (2014)

Identification of Plasma Thrombopoietin Level and Its Significance in Patients with Aplastic Anemia and Myelodysplastic Syndrome
por: Zhang, Mengying, et al.
Publicado: (2023)

Cephalosporin-induced recurrent aplastic anemia
por: Han, Jimin, et al.
Publicado: (2010)

Aplastic anemia, membranous nephropathy and mercury
por: Rooney, J.
Publicado: (2013)

Comparison of eltrombopag and avatrombopag in the treatment of refractory/relapsed aplastic anemia: a single-center retrospective study in China
por: Zhang, Zhuxin, et al.
Publicado: (2023)

Aplastic Anemia in China
por: Liu, Chunyan, et al.
Publicado: (2018)

Upregulated expression of leukocyte immunoglobulin-like receptor A3 in patients with severe aplastic anemia
por: Yu, Hong, et al.
Publicado: (2021)

Myeloid dendritic cells in severe aplastic anemia patients exhibit stronger phagocytosis
por: Sun, Yingying, et al.
Publicado: (2021)

PB2479: ELTROMBOPAG, BUT NOT AVATROMBOPAG, REGULATES BONE MARROW MICROENVIRONMENT MIMICKING APLASTIC ANEMIA THROUGH DOWN-REGULATION OF FERROPTOSIS INHIBITOR
por: Ji, Jiang, et al.
Publicado: (2023)

PB2041: COMPARISON OF ELTROMBOPAG AND AVATROMBOPAG IN THE TREATMENT OF REFRACTORY/RELAPSED APLASTIC ANEMIA, A SINGLE CENTER STUDY IN CHINA
por: Zhang, Zhuxin, et al.
Publicado: (2023)

Transfusion-dependent non-severe aplastic anemia: characteristics and outcomes in the clinic
por: Zhang, Yawen, et al.
Publicado: (2023)

SARS-CoV-2 infection in aplastic anemia
por: Avenoso, Daniele, et al.
Publicado: (2021)

Abnormal expression of histone acetylases in CD8+ T cells of patients with severe aplastic anemia
por: Qi, Weiwei, et al.
Publicado: (2022)

A cohort study of immune and hematopoietic functionality changes in severe aplastic anemia patients treated with immunosuppressive therapy
por: Guan, Jing, et al.
Publicado: (2019)

Lessons from a patient with severe aplastic anemia complicated with COVID-19
por: Wang, Yang, et al.
Publicado: (2021)

Arsenic trioxide improves hematopoiesis in refractory severe aplastic anemia
por: Li, Ning, et al.
Publicado: (2012)

Epstein Barr Virus Infection Affects Function of Cytotoxic T Lymphocytes in Patients with Severe Aplastic Anemia
por: Zhang, Tian, et al.
Publicado: (2018)

Successful sirolimus therapy of an aplastic anemia patient with chronic kidney disease: A case report
por: Niu, Haiyue, et al.
Publicado: (2020)

Single‐cell transcriptomic analysis of PB and BM NK cells from severe aplastic anaemia patients
por: Liu, Chunyan, et al.
Publicado: (2022)

Bone Marrow Plasma Cytokine Signature Profiles in Severe Aplastic Anemia
por: Liu, Bingnan, et al.
Publicado: (2020)

Identification of potential pathogenic genes for severe aplastic anemia by whole‐exome sequencing
por: Zhang, Yang, et al.
Publicado: (2022)

Management of aplastic anemia during the phase of defervescence of the COVID-19 pandemic()
por: Vallejo Llamas, Juan Carlos
Publicado: (2021)

Granulocyte Transfusion Combined with Granulocyte Colony Stimulating Factor in Severe Infection Patients with Severe Aplastic Anemia: A Single Center Experience from China
por: Wang, Huaquan, et al.
Publicado: (2014)

Traditional Chinese medicine for treating aplastic anemia
por: Guan, Jing, et al.
Publicado: (2023)

De-escalation empirical antibiotic therapy improved survival for patients with severe aplastic anemia treated with antithymocyte globulin
por: Fu, Rong, et al.
Publicado: (2017)

Analysis of the Efficacy and Safety of Avatrombopag Combined With MSCs for the Treatment of Thrombocytopenia After Allogeneic Hematopoietic Stem Cell Transplantation
por: Zhu, Lidan, et al.
Publicado: (2022)

Effectiveness and Safety of Avatrombopag in Liver Cancer Patients with Severe Thrombocytopenia: Real-World Data and Challenges
por: Huang, Ao, et al.
Publicado: (2022)

The shortening telomere length of T lymphocytes maybe associated with hyper-function in servere aplastic anemia
por: Wang, Chaomeng, et al.
Publicado: (2018)

Upregulated Expression of Profilin1 on Dendritic Cells in Patients With Severe Aplastic Anemia
por: Yu, Hong, et al.
Publicado: (2021)

HLA-matched sibling transplantation with G-CSF mobilized PBSCs and BM decreases GVHD in adult patients with severe aplastic anemia
por: Zi-Min, Sun, et al.
Publicado: (2010)

Recombinant Human Thrombopoietin Treatment Promotes Hematopoiesis Recovery in Patients with Severe Aplastic Anemia Receiving Immunosuppressive Therapy
por: Wang, Huaquan, et al.
Publicado: (2015)

Plasma Metabolomic and Intestinal Microbial Analyses of Patients With Severe Aplastic Anemia
por: Shao, Yuanyuan, et al.
Publicado: (2021)

Predicting Response of Severe Aplastic Anemia to Rabbit-Antithymocyte Immunoglobulin Based Immunosuppressive Therapy Combined With Eltrombopag
por: Li, Ruixin, et al.
Publicado: (2022)

The Impact of Eltrombopag Administration on the Clinical Course of Severe Refractory Fatal Acquired Aplastic Anemia
por: Işık, Ayşe, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_nco4qrbcf48tqvs4c3n7g3t564